375 related articles for article (PubMed ID: 16783610)
1. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.
Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610
[TBL] [Abstract][Full Text] [Related]
2. Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study.
Soegaard M; Jensen A; Høgdall E; Christensen L; Høgdall C; Blaakaer J; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1160-6. PubMed ID: 17548679
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
Jordan SJ; Green AC; Whiteman DC; Webb PM;
Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for benign serous and mucinous epithelial ovarian tumors.
Jordan SJ; Green AC; Whiteman DC; Webb PM
Obstet Gynecol; 2007 Mar; 109(3):647-54. PubMed ID: 17329516
[TBL] [Abstract][Full Text] [Related]
6. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoking and risk of epithelial ovarian cancer.
Rossing MA; Cushing-Haugen KL; Wicklund KG; Weiss NS
Cancer Causes Control; 2008 May; 19(4):413-20. PubMed ID: 18080774
[TBL] [Abstract][Full Text] [Related]
8. Use of dairy products, lactose, and calcium and risk of ovarian cancer - results from a Danish case-control study.
Faber MT; Jensen A; Søgaard M; Høgdall E; Høgdall C; Blaakaer J; Kjaer SK
Acta Oncol; 2012 Apr; 51(4):454-64. PubMed ID: 22397392
[TBL] [Abstract][Full Text] [Related]
9. Histologic types of epithelial ovarian cancer: have they different risk factors?
Kurian AW; Balise RR; McGuire V; Whittemore AS
Gynecol Oncol; 2005 Feb; 96(2):520-30. PubMed ID: 15661246
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
11. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy outcome and recurrence after conservative laparoscopic surgery for borderline ovarian tumors.
Tinelli FG; Tinelli R; La Grotta F; Tinelli A; Cicinelli E; Schönauer MM
Acta Obstet Gynecol Scand; 2007; 86(1):81-7. PubMed ID: 17230294
[TBL] [Abstract][Full Text] [Related]
13. Timing of pregnancy and the risk of epithelial ovarian cancer.
Whiteman DC; Siskind V; Purdie DM; Green AC
Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):42-6. PubMed ID: 12540502
[TBL] [Abstract][Full Text] [Related]
14. Breastfeeding and risk of epithelial ovarian cancer.
Jordan SJ; Siskind V; C Green A; Whiteman DC; Webb PM
Cancer Causes Control; 2010 Jan; 21(1):109-16. PubMed ID: 19779839
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
[TBL] [Abstract][Full Text] [Related]
16. Epidemiologic differences between women with borderline ovarian tumors and women with epithelial ovarian cancer.
Eltabbakh GH; Natarajan N; Piver MS; Mettlin CJ
Gynecol Oncol; 1999 Jul; 74(1):103-7. PubMed ID: 10385559
[TBL] [Abstract][Full Text] [Related]
17. Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study.
Rasmussen ELK; Hannibal CG; Dehlendorff C; Baandrup L; Junge J; Vang R; Kurman RJ; Kjaer SK
Gynecol Oncol; 2017 Mar; 144(3):571-576. PubMed ID: 28108026
[TBL] [Abstract][Full Text] [Related]
18. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
Mayr D; Hirschmann A; Löhrs U; Diebold J
Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
[TBL] [Abstract][Full Text] [Related]
19. Surgery of borderline tumors of the ovary: retrospective comparison of short-term outcome after laparoscopy or laparotomy.
Ødegaard E; Staff AC; Langebrekke A; Engh V; Onsrud M
Acta Obstet Gynecol Scand; 2007; 86(5):620-6. PubMed ID: 17464594
[TBL] [Abstract][Full Text] [Related]
20. Smoking and overweight: negative prognostic factors in stage III epithelial ovarian cancer.
Kjaerbye-Thygesen A; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):798-803. PubMed ID: 16614126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
